Midwest Clinical Research
Generated 5/10/2026
Executive Summary
Midwest Clinical Research (MCR), operating as Ohio Clinical Trials (OCT), is a well-established clinical research organization (CRO) and dedicated research site based in Dayton, Ohio. Founded in 1994, MCR provides comprehensive Phase I-III clinical trial services to pharmaceutical sponsors and CROs, with a strong specialization in early-phase and complex studies. The company operates a large, fully-equipped inpatient facility capable of housing participants for extended periods, positioning it as a key resource for trials requiring intensive monitoring and long-duration stays. With over 25 years of experience in the midwest clinical research landscape, MCR has built a reputation for reliable, high-quality trial execution, particularly in therapeutic areas requiring close patient management.
Upcoming Catalysts (preview)
- Q3 2026Major PhRMA Company Phase I Contract Win70% success
- Q1 2027Inpatient Facility Capacity Expansion65% success
- Q4 2026Strategic Partnership for Complex Oncology Studies60% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)